RT Journal Article
SR Electronic
T1 Retrospective survey from Vascular Access Team Lombardy Net in COVID-19 era
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.03.20222810
DO 10.1101/2020.11.03.20222810
A1 Antonio, Gidaro
A1 Davide, Vailati
A1 Marco, Gemma
A1 Francesca, Lugli
A1 Francesco, Casella
A1 Chiara, Cogliati
A1 Antonio, Canelli
A1 Cremonesi, Nadia
A1 Davide, Monolo
A1 Giuseppe, Cordio
A1 Chiara, Frosi
A1 Riccardo, Destefanis
A1 Anna, Rossi
A1 Chiara, Alemanno Maria
A1 Franco, Valenza
A1 Stefano, Elli
A1 Andrea, Caldarini
A1 Alberto, Lucchini
A1 Stefano, Paglia
A1 Monica, Baroni
A1 Davide, Giustivi
YR 2020
UL http://medrxiv.org/content/early/2020/11/05/2020.11.03.20222810.abstract
AB Background Venous Access Devices (VADs) are the most used device in COVID-19 patients.Objective Identify VADs implanted, catheter related thrombosis (CRT), catheter-related bloodstream infection (CRBSI), and accidental remove of VADs in both COVID-19 positive and COVID-19 free patients. Successive analysis was conducted comparing COVID-19 positive patients with COVID-19 free with inverse probability propensity score weights using simple regression to account for these two confounders (peripheral tip as central/peripheral and hospitalization as no/yes).Methods This multicenter, retrospective cohort study was conducted using data from 7 hospitals in Lombardy during the pandemic period from February 21st to May 31st 2020.Results 2206 VADs were evaluated, of which 1107 (50.2%) were inserted in COVID-19 patients. In COVID-19 cohort the first choice was Long Peripheral Cannula in 388 patients (35.1%) followed by Midline Catheter in 385 (34.8%). The number of “central tip” VADs inserted in COVID-free inpatients and COVID-19 positive were similar (307vs334). We recorded 42 (1.9%) CRT; 32 (79.2%) were observed in COVID-19 patients. 19 CRBSI were diagnosed; 15 (78.95%) were observed in COVID-19. Accidental removals were the more represented complication with 123 cases, 85 (69.1%) of them were in COVID-19. COVID-19 significantly predicted occurrence of CRT (OR = 2.00(1.85-5.03); P<0.001), CRSB (OR = 3.82(1.82-8.97); P<0.001), and Accidental Removal (OR = 2.39(1.80-3.20); P<0.001) in our propensity score weighted models.Conclusions CRT, CRBSI, and accidental removal are significantly more frequent in COVID-19 patients. Accidental removals are the principal complication, for this reason use of subcutaneously anchored securement is recommended for shorter period than usual.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Authors declare no conflicts of interest, no financial support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study (REGISTRO DELLE INFEZIONI SOSPETTE E ACCERTATE COVID-19/Studio Sacco COVID-19) was approved by the local ethical committee Milan Area 1 in ASST Fatebenefratelli Sacco, University Hospital Luigi Sacco with the registration number 2020/16088.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data supporting the findings of this study are available from the corresponding author upon reasonable request.